Dataset Information

Stakeholder perspectives towards the use of toxicants for managing wild pigs.

ABSTRACT: Wild pigs (Sus scrofa) are one of the most detrimental invasive mammals in the US. Lack of adequate population control has allowed pigs to become established across the landscape, causing significant ecological and economic damage. Given the need for additional tools for reducing wild pig populations, two toxicants, warfarin and sodium nitrite, are at the forefront of the discussion regarding future wild pig management. However, no research has examined stakeholders' perspectives towards the use of toxicants in wild pig management. Given the lack of knowledge, our goal was to determine stakeholders' perspectives towards the legal use of toxicants for managing wild pigs. We surveyed 1822 individuals from three stakeholder groups (hunters, farmers, and forestland owners) across Alabama during February 2018 using an online survey following the Tailored Design Method. All three stakeholder groups were generally supportive of toxicant use, though their views differed slightly by group. Furthermore, all stakeholder groups were supportive of toxicant purchasing and use regulations, while accidental water contamination, human health impact, and incorrect usage of a toxicant were stakeholders' greatest concerns. These results indicate that these groups would likely be in support of using toxicants for wild pig management in Alabama and could be a model for other states or locations. Consequently, these results have direct implications for shaping policy and possible use of toxicants as a future wild pig management tool.

SUBMITTER: Tucker Williams E

PROVIDER: S-EPMC7870098 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Stakeholder perspectives towards the use of toxicants for managing wild pigs.

Tucker Williams Ellary E Lepczyk Christopher A CA Morse Wayde W Smith Mark M

PloS one 20210205 2

Wild pigs (Sus scrofa) are one of the most detrimental invasive mammals in the US. Lack of adequate population control has allowed pigs to become established across the landscape, causing significant ecological and economic damage. Given the need for additional tools for reducing wild pig populations, two toxicants, warfarin and sodium nitrite, are at the forefront of the discussion regarding future wild pig management. However, no research has examined stakeholders' perspectives towards the use ...[more]

PMID: 33544753

Similar Datasets

Project description:Although pharmacists are entrusted to play a role in ensuring the safe and appropriate use of all medicines, in general, the inclusion of complementary medicines (CMs) into their professional practice has not been observed. The purpose of this study was to explore the perceptions and opinions of pharmacists and 8 key stakeholder leaders regarding the barriers that hinder pharmacists from providing care related to the use of CMs by patients/consumers and to identify solutions that would support pharmacists' in extending their role in this area.Semi-structured key informant interviews were conducted with 2 practicing pharmacists, 1 pharmacy owner, 1 key representative of a pharmacist professional organization, 1 key representative of a consumer advocacy group, 1 key representative of a medical professional organization, 1 key representative from a complementary medicine practitioner professional organization, 1 leader within a pharmacy school, 2 senior staff from a regulatory authority, and 1 key representative of the complementary medicine industry in Australia.A total of 9 barriers were identified in this study. Barriers including a lack of CMs knowledge, doubts about the evidence-base, a lack of research skills and access to reliable and reputable information dominated the discussions. A total of 7 solutions were proposed. Of those, the integration of CMs curricula into under-graduate and professional pharmacy education, and defining a clearer role for pharmacists' standard of practice were considered the most important. Apposing opinions about the role of naturopaths in pharmacies were identified..It is anticipated that pharmacists will be required to formalise a role in ensuring the safe and appropriate use of complementary medicines to fulfil their professional and ethical responsibilities. However, pharmacists in general are not ready to take up this extended role. Individual key stakeholder groups have considered the existing barriers and have proposed solutions that are isolated measures. To facilitate further developments related to CMs and the professional practice of pharmacy, collaborative efforts between key stakeholders are needed to strategically plan and execute an extended role in a unified manner.

Project description:Exoskeleton technology has potential benefits for wheelchair users' health and mobility. However, there are practical barriers to their everyday use as a mobility device. To further understand potential exoskeleton use, and facilitate the development of new technologies, a study was undertaken to explore perspectives of wheelchair users and healthcare professionals on reasons for use of exoskeleton technology, and the importance of a variety of device characteristics.An online survey with quantitative and qualitative components was conducted with wheelchair users and healthcare professionals working directly with individuals with mobility impairments. Respondents rated whether they would use or recommend an exoskeleton for four potential reasons. Seventeen design features were rated and compared in terms of their importance. An exploratory factor analysis was conducted to categorize the 17 design features into meaningful groupings. Content analysis was used to identify themes for the open ended questions regarding reasons for use of an exoskeleton.481 survey responses were analyzed, 354 from wheelchair users and 127 from healthcare professionals. The most highly rated reason for potential use or recommendation of an exoskeleton was health benefits. Of the design features, 4 had a median rating of very important: minimization of falls risk, comfort, putting on/taking off the device, and purchase cost. Factor analysis identified two main categories of design features: Functional Activities and Technology Characteristics. Qualitative findings indicated that health and physical benefits, use for activity and access reasons, and psychosocial benefits were important considerations in whether to use or recommend an exoskeleton.This study emphasizes the importance of developing future exoskeletons that are comfortable, affordable, minimize fall risk, and enable functional activities. Findings from this study can be utilized to inform the priorities for future development of this technology.

Project description:BackgroundAdaptive clinical trials (ACTs) represent an emerging approach to trial design where accumulating data are used to make decisions about future conduct. Adaptations can include comparisons of multiple dose tiers, response-adaptive randomization, sample size re-estimation, and efficacy/futility stopping rules. The objective of this scoping review is to assess stakeholder attitudes, perspectives, and understanding of adaptive trials.MethodsWe conducted a review of articles examining stakeholders encompassing the broad medical trial community's perspectives of adaptive designs (ADs). A computerized search was conducted of four electronic databases with relevant search terms. Following screening of articles, the primary findings of each included article were coded for study design, population studied, purpose, and primary implications.ResultsOur team retrieved 167 peer-reviewed titles in total from the database search and 5 additional titles through searching web-based search engines for gray literature. Of those 172 titles, 152 were non-duplicate citations. Of these, 119 were not given full-text reviews, as their titles and abstracts indicated that they did not meet the inclusion criteria. Thirty-three articles were carefully examined for relevance, and of those, 18 were chosen to be part of the analysis; the other 15 were excluded, as they were not relevant upon closer inspection. Perceived advantages to ADs included limiting ineffective treatments and efficiency in answering the research question; -perceived barriers included insufficient sample size for secondary outcomes, challenges of consent, potential for bias, risk of type 1 error, cost and time to adaptively design trials, unclear rationales for using Ads, and, most importantly, a lack of education regarding ADs among stakeholders within the clinical trial community. Perceptions among different types of stakeholders varied from sector to sector, with patient perspectives being noticeably absent from the literature.ConclusionThere are diverse perceptions regarding ADs among stakeholders. Further training, guidelines, and toolkits on the proper use of ADs are needed at all levels to overcome many of these perceived barriers. While education for principal investigators is important, it is also crucial to educate other groups in the community, such as patients, as well as clinicians and staff involved in their daily implementation.

Dataset Information

Stakeholder perspectives towards the use of toxicants for managing wild pigs.

Publications

Stakeholder perspectives towards the use of toxicants for managing wild pigs.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets